Clinical trials
Completed Polycystic Ovary Syndrome trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
97 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 7 |
| 2007 | 7 |
| 2008 | 5 |
| 2009 | 9 |
| 2010 | 3 |
| 2011 | 7 |
| 2012 | 5 |
| 2013 | 6 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 97 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cornell University | 6 |
| Milton S. Hershey Medical Center | 6 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 4 |
| University of California, San Diego | 4 |
| University of Colorado, Denver | 4 |
| Woman's | 4 |
| Yale University | 4 |
| University of California, San Francisco | 3 |
| University of Michigan | 3 |
| Mayo Clinic | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Polycystic Ovary Syndrome | 97 |
| Insulin Resistance | 17 |
| Obesity | 17 |
| Hyperandrogenism | 12 |
| Anovulation | 10 |
| Infertility | 10 |
| Overweight | 8 |
| Menstruation Disturbances | 7 |
| Ovarian Cysts | 4 |
| Amenorrhea | 3 |
Trials
Showing 1 to 25 of 97. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.